Company profile for Walvax Biotechnology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2001, Walvax Biotechnology Co., Ltd. (Walvax) is a leading vaccine producer, engaged in research and development, manufacturing and distribution of safe and efficacious quality vaccines. Headquartered in China’s southwestern city Kunming in Yunnan Province, Walvax went to IPO in 2010 (300142.SZ) and started business expansion from traditional vaccines to innovative vaccines. With the vision of dedicating to be the...
Founded in 2001, Walvax Biotechnology Co., Ltd. (Walvax) is a leading vaccine producer, engaged in research and development, manufacturing and distribution of safe and efficacious quality vaccines. Headquartered in China’s southwestern city Kunming in Yunnan Province, Walvax went to IPO in 2010 (300142.SZ) and started business expansion from traditional vaccines to innovative vaccines. With the vision of dedicating to be the pride domestically and the pioneer globally in the vaccine industry, producing efficacious, quality, innovative and affordable products to protect people from the world’s deadliest diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
19/F Bldg.9A, Dingyi Tiancheng Residential Quarter, Keyuan Road No. 99, High &...
Telephone
Telephone
+ (86) 871-68312659
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/business/healthcare-pharmaceuticals/who-says-wider-alert-contaminated-jj-cough-syrup-likely-2024-04-19/

Andrew Silver REUTERS
19 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/indonesia-drug-agency-approves-chinas-walvax-mrna-vaccine-emergency-use-2022-09-29/

Stanley Widianto REUTERS
29 Sep 2022

https://www.hengkangpharm.cn/new_detail_en/id/2.html

PRESS RELEASE
26 Jul 2022

https://www.reuters.com/business/healthcare-pharmaceuticals/chinese-mrna-covid-booster-stronger-against-omicron-than-sinovac-shot-trial-data-2022-06-01/

Roxanne Liu REUTERS
01 Jun 2022

https://endpts.com/with-covid-19-vaccine-in-limbo-chinas-fosun-inks-628m-deal-for-a-prevnar-13-rival/

Amber Tong ENDPTS
28 Oct 2021

https://www.yicaiglobal.com/news/walvax-biotech-soars-on-four-fold-gain-in-first-half-profit-mrna-shots-plan

YICAI GLOBAL
30 Aug 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty